Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | NAAA | Q02083 | 2/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1481768 | 1.00 | CYP1A2 (0.43) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL1481940 | 1.00 | CYP1A2 (0.43) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL65833 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL891828 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL892025 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL6263591 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL8769510 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL6715525 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL6716866 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL22042665 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116848094-A | Tertiary amine lipid compounds and uses thereof | 华南理工大学 | 2023-10-03 | — | — | CN | claimed |
| WO-2023125184-A1 | TERTIARY AMINE LIPID COMPOUND AND USE THEREOF | 华南理工大学 | 2023-07-06 | — | — | WO | claimed |
| EP-2504288-B1 | OPTICAL FIBER WITH DOUBLE COATING | PRYSMIAN SPA (IT) | 2019-04-17 | — | — | EP | claimed |
| EP-2504288-A1 | OPTICAL FIBER WITH DOUBLE COATING | Prysmian S.p.A. (IT) | 2012-10-03 | — | — | EP | claimed |
| WO-2011063838-A1 | OPTICAL FIBER WITH DOUBLE COATING | PRYSMIAN S.P.A. (IT) | 2011-06-03 | — | — | WO | claimed |
| US-6521262-B2 | Therapeutic active substances or active substance concentrates, in particular lipid conjugates of nucleosides which have gel-forming properties in aqueous media | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2003-02-18 | — | — | US | claimed |
| EP-0877605-B1 | SOLID INSTANT-RELEASE FORMS OF ADMINISTRATION AND PROCESS FOR PRODUCING THE SAME | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2002-10-16 | — | — | EP | claimed |
| US-20020122817-A1 | SOLID INSTANT-RELEASE FORMS OF ADMINISTRATION AND PROCESS FOR PRODUCING THE SAME | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2002-09-05 | — | — | US | claimed |
| EP-0869817-B1 | COVALENT LIPID-PHOSPHONO-CARBOXYLIC ACID CONJUGATES AND APPLICATION THEREOF AS ANTIVIRAL MEDICAMENTS | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2002-06-19 | — | — | EP | claimed |
| JP-2000505784-A | — | — | 2000-05-16 | — | — | JP | claimed |
| CN-1214629-A | Solid immediate release dosage form and process for preparing same | BOEHRINGER MANNHEIM GMBH (DE) | 1999-04-21 | — | — | CN | claimed |
| EP-0869817-A2 | COVALENT LIPID-PHOSPHONO-CARBOXYLIC ACID CONJUGATES AND APPLICATION THEREOF AS ANTIVIRAL MEDICAMENTS | Roche Diagnostics GmbH (DE) | 1998-10-14 | — | — | EP | claimed |
| WO-1997022368-A2 | COVALENT LIPID-PHOSPHONO-CARBOXYLIC ACID CONJUGATES AND APPLICATION THEREOF AS ANTIVIRAL MEDICAMENTS | BOEHRINGER MANNHEIM GMBH (DE) | 1997-06-26 | — | — | WO | claimed |
| WO-2024090402-A1 | LIQUID CRYSTAL ELEMENT AND EMULSION COMPOSITION | 三菱ケミカル株式会社 | 2024-05-02 | — | — | WO | disclosed |
| US-20240027430-A1 | Cell and Other Bio-Entity Identification and Counting | ESSENLIX CORPORATION (US) | 2024-01-25 | — | — | US | disclosed |
| CN-116848094-A | Tertiary amine lipid compounds and uses thereof | 华南理工大学 | 2023-10-03 | — | — | CN | disclosed |
| EP-0111448-A2 | Colour-photographic recording material | CIBA-GEIGY AG (CH) | 1984-06-20 | — | — | EP | disclosed |
| US-4452884-A | 2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL HYDROXYPHENYL ALKYL AMIDES OR ESTERS AS LIGHT STABILIZERS | CIBA-GEIGY AG (CH) | 1984-06-05 | — | — | US | disclosed |
| EP-0082817-A1 | Colour-photographic recording material | CIBA-GEIGY AG (CH) | 1983-06-29 | — | — | EP | disclosed |
| US-4202816-A | ENOL-PIPERIDINE METAL COMPLEXES | CIBA-GEIGY CORPORATION (US) | 1980-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020122817-A1 | SOLID INSTANT-RELEASE FORMS OF ADMINISTRATION AND PROCESS FOR PRODUCING THE SAME | ADAR, PAICS, GART | CYP1A2 1072/4885TSHR 812/4885NAAA 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.